Remembering the Past
Release time:
2020-08-14
Memories of Past
■ Qiubin Pharmaceutical Factory Wang Haibin
Sun and Moon are like flies. It has been more than 10 20 years since it entered the peak. It was in the late 1990 s. With the deepening of reform and opening up and the restructuring of state-owned enterprises, many employees of state-owned enterprises, including me, were faced with life choices. At that time, there were many employment plans to choose from. I chose Jianfeng Group, because Jianfeng was the only listed company at the same level in Jinhua City at that time, and many young people dreamed of entering. Shortly after my resume was submitted, I successfully received the notice to go to work. At that time, I was very excited and felt that I had a platform to struggle and rely on.
Shortly after I went to work at the peak, I was assigned to the preparatory group of the Pharmaceutical Development Company to engage in the "Special New" disinfectant project transferred from Tianjin Medical Institute. In those years, due to the macro-control of national infrastructure projects and the depression of the cement industry, the group company made a strategic plan to enter the pharmaceutical industry. "Special New" was the first project of Jianfeng Pharmaceutical Development Company, and its significance can be imagined. We are all very excited to be the first batch of workers in the peak medical project, and we also feel the great burden and responsibility on our shoulders.
At that time, the personnel of the project team were basically transferred from outside, including Huang Fu Xiaosheng, a government cadre from Lanxi City, Zheng Yinghua, a process engineer, Wang Yulin, an equipment engineer, Huang Chaoyun and Yang Xiaojuan, chief engineers of the original dyeing and chemical plant, and Li Chengxiang, who graduated from Peking University. These new peak people from all over the world have a common wish, hoping that through the team and their own efforts, the project will be put into effect as soon as possible and contribute to the diversified development of the peak. Some of these former colleagues have retired, some have left the peak, and the memory of them has gradually blurred over time, but the past of those who worked together is still fresh in my mind. During the period of
, the colleagues of the project team worked hard according to the division of labor, day and night. Like everyone else, I do everything well. After careful study and calculation of the pilot scheme and design drawings submitted by Tianjin Medical Institute, according to the accumulation of previous work, the process flow chart with control points and the layout of equipment level and elevation are re-optimized and designed. The process equipment is arranged three-dimensionally according to the reaction steps and operation units. The plant space is reasonably utilized, and the equipment operation, maintenance and production control are more convenient and reliable.
The work during the trial production period is even more complicated. In addition to debugging the machine, we also need to organize raw and auxiliary materials, formulate process regulations, carry out staff training, prepare the trial production plan, etc. Everyone is very busy. The most worrying thing is that the project involves many flammable, explosive, toxic and hazardous chemicals such as toluene, chlorobenzene, n-hexane, ethanol, acetic acid, etc. At that time, the hydrogenation reduction and diazotization reactions in the production process have now been The national safety supervision department determines that it is a dangerous production process, and the requirements for fire and explosion prevention are particularly high. Most of our operators are transferred from cement plants and lack understanding of chemical production. Although they have conducted strict training and assessment before, they have no perceptual knowledge of hazardous chemicals, and they are often careless and random in their work. As a result, several small safety production accidents and attempted accidents occurred. In view of these situations, we have strengthened post inspection and hidden danger investigation, strengthened safety education, training and assessment, especially through strict implementation of hot work, inspection and maintenance and other work permit systems, and strengthened the inspection and assessment of "three violations" to prevent the occurrence of more accidents. Looking back on those days, it was precisely because we practiced the peak spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top, and forever climbing the peak" that we could complete the project design, equipment installation and trial production in less than half a year.
Although "Texin" was discontinued later due to market changes and improved management requirements, the pace of development of our peak pharmaceutical industry has not stopped. The product "Shu Jiaqing" of the Jiangnan Factory of Dier Pharmaceutical, a joint venture with Dier Pharmaceutical, is sold well in the north and south of the Yangtze River. The merger of Jinhua Biochemical Pharmaceutical Factory and the registration of Zhejiang Jianfeng Pharmaceutical Co., Ltd. have entered a healthy development track since then. With the cephalosporin powder injection preparation workshop, solid preparation workshop and Qiubin Pharmaceutical Factory of Jiangnan Factory of Jianfeng Pharmaceutical Co., Ltd. successively completed and put into operation, new products such as azithromycin, gatifloxacin, Lester, paroxetine and cefmenoxime were successively introduced, and Jinxi Factory, which is in line with international counterparts, was built in 2014 . The enterprise is growing day by day, the technology and equipment are becoming more and more advanced, and the efficiency is getting better and better. As a participant who has witnessed the development of Jianfeng Pharmaceutical from scratch, from small to large, and from weak to strong, I have witnessed the leaders and colleagues who have worked hard for this all the way, and also shared the achievements and joy brought by the development of the enterprise. I deeply realize that only when the enterprise develops can we realize our ideals; only when the employees of the enterprise work hard can the enterprise develop. The individual is a seed, the enterprise is the fertile land, the seed only buried in the fertile land, it is possible to thrive.
Past is like smoke, years are like songs. On the 33rd anniversary of peak start-up 60#, recalling these past events, I am deeply gratified that I decided to come to peak, and proud that I am a peak person! Dripping water en Yongquan newspaper, a mi en thousand dou also. Thanks to the peak for giving us such a platform for development, and thanks to the peak leadership team that led us all the way forward. As an old employee, I will try my best to stand on the last shift. I hope that the young scientific and technological workers of the peak will cherish the development platform provided by the enterprise, motivate themselves with the spirit of the peak, continue to innovate, and strive to create a beautiful century-old peak!
More information
Yunnan peak through the safety standard secondary acceptance
On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate
2020
07-30
Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory
News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Peak health marketing and a new "play"
Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)
2020
07-31
Accident-free factory creation enters "second season"
At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open
2020
07-31
What will the Chinese Medicine Act bring us?
At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page